← FDA DRUG APPROVALS

FDA NDA · NDA017084

PHOSPHOCOL P32

Sponsor: CURIUM

APPLICATION
NDA017084
TYPE
NDA
ORIGINAL APPROVAL
1974-09-23
LATEST ACTION
2009-05-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PHOSPHOCOL P32Discontinued
CHROMIC PHOSPHATE P-32 5mCi/ML · INJECTABLE · INJECTION

Approval history

2009-05-22Labeling · Supplement 17 · standardLabelAP
2008-08-29Labeling · Supplement 16 · standardLetterAP
2001-08-28Manufacturing (CMC) · Supplement 15 · standardAP
1998-04-22Manufacturing (CMC) · Supplement 14 · standardAP
1994-09-30Manufacturing (CMC) · Supplement 13 · standardAP
1994-03-30Manufacturing (CMC) · Supplement 12 · standardAP
1990-05-10Manufacturing (CMC) · Supplement 11 · standardAP
1989-04-24Manufacturing (CMC) · Supplement 5 · standardAP
1983-03-31Manufacturing (CMC) · Supplement 8 · standardAP
1982-05-07Manufacturing (CMC) · Supplement 7 · standardAP
1977-08-23Manufacturing (CMC) · Supplement 4 · standardAP
1977-07-27Manufacturing (CMC) · Supplement 3 · standardAP
1977-04-29Manufacturing (CMC) · Supplement 2 · standardAP
1977-04-29Labeling · Supplement 1AP
1974-09-23Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →